ABSTRACT

If biotechnology describes the exploitation of living systems or their products towards biomedical processes, then few entities have a greater biotechnological potential than the use of bacteriophages to cure human illness. Many researchers studying infectious diseases have little doubt that phage therapy has a contribution to make and will achieve mainstream medical relevance in the 21st century. This would come not a moment too soon. Today multi-drug-resistant and “extremely” drug-resistant forms of pathogens are reaching epidemic proportions and causing death on a global scale.